Background The therapeutic use of monoclonal antibodies (mAbs) has significantly increased since the first mAb was introduced. Despite their therapeutic benefits, mAbs have been accompanied by a rise

DataCite Commons2025-04-19 更新40

Toxicity profiles associated with EGFR-TKIs combined with angiogenesis inhibitors in non-small cell lung cancer: an epidemiological surveillance analysis of the FDA adverse event reporting system

毒性

药物警戒

Ongoing studies are evaluating the efficacy and toxicity profiles of combining epidermal growth factor receptor inhibitors (EGFR-TKIs) with antiangiogenic agents in non-small cell lung cancer (NSCLC).

Taylor & Francis Group2025-10-02 更新20

Drug-induced skin ulcer: real-world pharmacovigilance analysis based on the FDA adverse event reporting system

药物不良反应监测

药物警戒

Skin ulcer (SU) may increase the risk of systemic infections and have evolved into an important public health problem. However, there is a lack of research specifically on drug-induced SU. We extracte

Taylor & Francis Group2025-05-14 更新40

428 PTs that met the four assessment criteria.

药物安全监测

不良药物反应

BackgroundThis study aims to assess the adverse events (AEs) and safety profile of omeprazole, a widely used proton pump inhibitor (PPI) for acid-related diseases. Despite being a first-line treatment

Figshare2025-08-20 更新30

Causality and avoidability assessments of the adverse drug reactions in hospital in-patients.

资源简介：

相关数据集